06/08/2009 Last weekend a European study regarding the use of CA 125 testing in ovarian cancer patients was presented at the American Society of Clinical Oncologists (ASCO) Annual Meeting. The study’s results indicate that women with relapsed ovarian cancer did not live longer if chemotherapy was started earlier based on a rising CA 125, as opposed to … Continued
03/17/2009 Today, the Ovarian Cancer Research Fund (OCRF) announced its most recent research grant recipients. Grants were awarded in three different categories: the Program Project Development Grant, the Liz Tilberis Award, and the Ovarian Cancer Research Training Program of Excellence. The grants, awarded to seventeen researchers at twelve research institutions, totaled over 5 million dollars. … Continued
On February 5, 2009, OCRF, in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of … Continued
Anil Sood, MD, Principal Investigator of the MD Anderson Cancer Center Program Project Development Grant, is featured in the December 17 Wall Street Journal article "Cancer Study Explores Role of 2 Proteins."
OCRF Partners with GCF to Continue Ovarian Cancer Symptoms Research Gynecologic Cancer Foundation Bulletin Summer 2008
On June 13, 2007, the New York Times published the article “Symptoms Found for Early Check on Ovary Cancer”. The front page article stressed the importance for women and doctors to be familiar with the early symptoms of ovarian cancer, previously believed to have no warning until in its advanced stages.
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
